At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 enrolled
Drug / intervention
OCS™ Liver System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
International Randomized Trial to Evaluate The Effectiveness of The Portable Organ Care System (OCS™) Liver For Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT Trial)
In Brief
A clinical study evaluating OCS™ Liver System and Control for Liver Transplantation and Liver Preservation for Transplant. Completed, enrolled 300 participants across 20 sites.
Detailed Summary
A prospective, phased-pivotal, international randomized trial to evaluate the effectiveness of the OCS™ Liver to preserve and assess donor livers intended for transplantation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 2015
Enrollment StartJan 2016
Primary CompletionOct 2019
Study CompletionNov 2021
TodayJul 2026
First PostedAug 13, 2015
Enrollment StartJan 24, 2016
Primary CompletionOct 22, 2019
Study CompletionNov 5, 2021
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 10.9 years ago
Interventions
OCS™ Liver Systemdevice
Controlother